Toward Zero Variance in Proteomics Sample Preparation: Positive-Pressure FASP in 96-Well Format (PF96) Enables Highly Reproducible, Time- and Cost-Efficient Analysis of Sample Cohorts.
Stefan LorochDominik KopczynskiAdriana C SchneiderCornelia SchumbrutzkiIngo FeldmannEleftherios PanagiotidisYvonne ReindersRoman SaksonFiorella A SolariAlicia VeningFrauke SwieringaJohan W M HeemskerkMaria GrandochThomas DandekarAlbert SickmannPublished in: Journal of proteome research (2022)
As novel liquid chromatography-mass spectrometry (LC-MS) technologies for proteomics offer a substantial increase in LC-MS runs per day, robust and reproducible sample preparation emerges as a new bottleneck for throughput. We introduce a novel strategy for positive-pressure 96-well filter-aided sample preparation (PF96) on a commercial positive-pressure solid-phase extraction device. PF96 allows for a five-fold increase in throughput in conjunction with extraordinary reproducibility with Pearson product-moment correlations on the protein level of r = 0.9993, as demonstrated for mouse heart tissue lysate in 40 technical replicates. The targeted quantification of 16 peptides in the presence of stable-isotope-labeled reference peptides confirms that PF96 variance is barely assessable against technical variation from nanoLC-MS instrumentation. We further demonstrate that protein loads of 36-60 μg result in optimal peptide recovery, but lower amounts ≥3 μg can also be processed reproducibly. In summary, the reproducibility, simplicity, and economy of time provide PF96 a promising future in biomedical and clinical research.
Keyphrases
- mass spectrometry
- liquid chromatography
- solid phase extraction
- molecularly imprinted
- high performance liquid chromatography
- tandem mass spectrometry
- gas chromatography
- high resolution mass spectrometry
- simultaneous determination
- capillary electrophoresis
- ultra high performance liquid chromatography
- liquid chromatography tandem mass spectrometry
- amino acid
- high resolution
- gas chromatography mass spectrometry
- heart failure
- binding protein
- multiple sclerosis
- atrial fibrillation
- drug delivery
- positron emission tomography
- cancer therapy